Dr. Greg Wang is a faculty member of Department of Pharmacology and Cancer Biology, Department of Pathology (adjunct), and  Duke Cancer Institute, Duke University Medical School.  He has enormous passion both for scientific discovery and for addressing critical health needs we face. His active research programs cover the fundamental principles of chromatin biology and gene regulation, pathogenesis notably cancer, and therapeutics. He also develops high interest in studying how host tames virus via epigenetic mechanisms.
    Dr. Wang holds a James B. Duke Distinguished Professorship in Pharmacology and Cancer Biology and received a set of recognitions, including a Young Investigator Award of American Society for Biochemistry & Molecular Biology (2021), the Phillip and Ruth Hettleman Prize for Artistic and Scholarly Achievement (2019; UNC-CH) and the Yang Family Biomedical Scholar (2020), several awards of private foundations such as American Cancer Society Scholar (2016) and Leukemia & Lymphoma Society Scholar (2018), amongst others (see CV below). Before joining UNC (2012-23) and Duke (2023-present) as a faculty member, he had completed a PHD study at UCSD and a postdoctoral training with Dr. C David Allis at Rockefeller University (2007-2011).